Minami Fujiwara Yamada

A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: β2-microglobulin associated with time to progression

K. Ishizawa, H. Harigae, Y. Onishi, 2009, International journal of hematology.